Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 196 to 210 of 475 results for %s

  1. Assessing motility of the gastrointestinal tract using a wireless capsule (IPG502)

    Evidence-based recommendations on assessing motility of the gastrointestinal tract using a wireless capsule. This involves swallowing a capsule that sends bowel information as it passes through the digestive system.

    Interventional procedures guidance
    Published
    23 August 2014
    View recommendations

    Sections for IPG502

  2. Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

    NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease .

    Medtech innovation briefing
    Published
    4 December 2017

  3. Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction (IPG205)

    Evidence-based recommendations on fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction. This involves inserting a tube with a flexible camera through small cuts in the mother's abdomen to identify and open any blockage.

    Interventional procedures guidance
    Published
    24 January 2007
    View recommendations

    Sections for IPG205

  4. Breastfeeding support for parents with twins or triplets: What support with breastfeeding do parents of twins or triplets find helpful?

    breastfeed. Full details of the research recommendation are in evidence review S: breastfeeding information and support. Source guidance...

    Research recommendation
    Published
    6 August 2021

  5. Optilume for anterior urethral strictures (MIB241)

    NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .

    Medtech innovation briefing
    Published
    5 January 2021

  6. AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)

    This advice has been updated and replaced by NICE medical technologies guidance 65.

    Medtech innovation briefing
    Published
    6 October 2020

  7. Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab (ESNM13)

    Summary of the evidence on subcutaneous trastuzumab for HER2-positive breast cancer to inform local NHS planning and decision-making

    Evidence summary
    Published
    13 March 2013

  8. Interim methods guide for developing service guidance 2014 (PMG8)

    Interim methods guide for developing service guidance 2014

  9. For people who have experienced suspected anaphylaxis, what is the effect on health-related quality of life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment alone?

    magnitude. It is recommended that data are collected using validated measure(s) of HRQoL, including EQ-5D. Source guidance details Comes...

    Research recommendation
    Published
    26 October 2020

  10. Cost effectiveness of daycare units for treating patients with an acute painful sickle cell episode:- Are daycare units cost effective compared with emergency settings for treating patients with an acute painful sickle cell episode?

    quality of life (HRQoL). Data should be collected using validated measure(s) of HRQoL, including EQ-5D Source guidance details Comes...

    Research recommendation
    Published
    9 June 2015

  11. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188)

    This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations on care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It also includes advice on organising services for long COVID.

    COVID-19 rapid guideline
    Last updated
    25 January 2024

    Sections for NG188

  12. Effect of specialist services on health-related quality of life:- For people who have experienced suspected anaphylaxis, what is the effect on health-related quality of life of (a) referral to specialist allergy services and (b) provision of adrenaline injectors, when compared with emergency treatment alone?

    magnitude. It is recommended that data are collected using validated measure(s) of HRQoL,including EQ-5D. Source guidance details Comes...

    Research recommendation
    Published
    9 June 2015

  13. myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

    NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease .

    Medtech innovation briefing
    Published
    1 October 2018

  14. ATEC system for vacuum-assisted breast biopsy (MIB43)

    NICE has developed a medtech innovation briefing (MIB) on the ATEC breast biopsy system

    Medtech innovation briefing
    Published
    10 November 2015

  15. Autoimmune haemolytic anaemia: rituximab (ESUOM39)

    Summary of the evidence on rituximab for treating autoimmune haemolytic anaemia (AIHA) to inform local NHS planning and decision-making

    Evidence summary
    Published
    10 February 2015